Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/1996
11/07/1996CA2219020A1 Tissue adhesive using synthetic cross-linking
11/06/1996EP0740791A1 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains
11/06/1996CN1135181A Alteration of immune response using pan Dr-binding peptides
11/05/1996US5571892 Polypeptide and anti-HIV drug prepared therefrom
11/05/1996US5571711 Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors
10/1996
10/31/1996WO1996034113A2 Methods for the identification of farnesyltransferase inhibitors
10/31/1996WO1996034012A1 Cyclic pentapeptide lh-rh receptor antagonists
10/31/1996WO1996033729A1 Antagonists of lhrh
10/31/1996CA2219263A1 Antagonists of lhrh
10/31/1996CA2215737A1 Lh-rh receptor antagonists
10/30/1996EP0739486A1 Synthetic receptors, libraries and uses thereof
10/30/1996EP0739211A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
10/30/1996CN1134706A Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
10/30/1996CN1134270A Center dispense suture package
10/29/1996US5569745 Peptide-Chelator conjugates
10/29/1996US5569741 Cyclic octapeptide neuromedin B receptor antagonists
10/29/1996US5569647 Angiopeptin cyclopeptide compounds
10/29/1996US5569646 Treatment of pneumonia; microbiocides, fungicides
10/24/1996WO1996033218A1 Anti-haemorrhagic peptides
10/24/1996WO1996033213A1 Method for preparing streptogramines
10/24/1996WO1996032954A1 Nitrosylated neuropeptides
10/24/1996CA2215991A1 Method for preparing streptogramines
10/23/1996EP0738320A1 Synthetic antimicrobial peptides
10/23/1996EP0738280A1 Superactive vip antagonists
10/23/1996EP0738154A1 N-terminus modified analogs of lhrh
10/23/1996EP0593491B1 Luteinizing hormone releasing hormone antagonist peptides
10/23/1996EP0422125B1 Platelet blocking peptides
10/23/1996EP0276262B1 Merozoite surface antigen of plasmodium falciparum
10/23/1996CN1134159A Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparation contg. these compounds
10/22/1996US5567681 PGLa and XPF peptides and uses therefor
10/22/1996US5567408 YIGSR peptide radiopharmaceutical applications
10/22/1996US5567317 Method to identify analyte-binding ligands
10/22/1996CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them
10/22/1996CA1338659C Method of healing wounds in horses
10/17/1996WO1996032410A1 Plant cell growth factors
10/17/1996WO1996032409A1 Plant cell growth factor
10/17/1996WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996WO1996032127A1 Methods of enhancing epithelial cell proliferation
10/17/1996WO1996032119A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2215389A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/16/1996EP0737691A1 Bombesin analogs
10/16/1996EP0737690A2 Antihypertensive agent and method for preparing same
10/16/1996EP0737232A1 Modular design and synthesis of aminimide containing molecules
10/16/1996EP0737208A1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
10/16/1996EP0737204A1 Cs-1 peptidomimetics, compositions and methods of using the same
10/16/1996EP0737076A1 Method for antigen-specific immunoregulation by t-cell alpha chain
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996EP0737073A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
10/16/1996EP0429477B1 Synthetic vaccine against aids virus
10/16/1996CN1033043C Process for preparation of glucuromide glycoside antibiotic A40926
10/15/1996US5565574 Preparation of phenylalanine derivatives bearing a 1,2,4-triazole moiety and their use in peptides
10/15/1996US5565425 Viral infection and proliferation inhibitors
10/15/1996US5565424 Vasoactive intestinal peptide antagonists useful as antitumor and anticancer agents
10/15/1996US5565423 Cyclopeptides and their use as absorption promoters when applied to the mucosa
10/15/1996CA1338653C Labeled derivatives of cyclosporins
10/10/1996WO1996031537A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/10/1996WO1996031531A2 Fluorescent peptides
10/10/1996WO1996031530A1 Novel peptides and remedy for bone diseases containing the same as active ingredient
10/10/1996WO1996031529A1 Peptides and remedy for autoimmune diseases comprising the same
10/10/1996WO1996031528A1 Beta sheet forming peptides and gels made thereof
10/10/1996WO1996031243A1 Ternary radiopharmaceutical complexes
10/10/1996WO1996031228A1 Cyclic peptide antifungal agents
10/10/1996WO1996012737A3 Compositions and treatment for multiple sclerosis
10/10/1996CA2217572A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/10/1996CA2217048A1 Cyclic peptide antifungal agents
10/09/1996EP0736541A1 Cyclic hexapeptide antifungal agents
10/09/1996EP0736179A1 Differentiation of htlv-i and htlv-ii using synthetic peptides
10/09/1996EP0736039A1 Compounds with growth hormone releasing properties
10/09/1996EP0736038A1 Compounds with growth hormone releasing properties
10/09/1996EP0736035A1 Pretargeting methods and compounds
10/09/1996EP0735893A1 Alteration of immune response using pan dr-binding peptides
10/09/1996EP0528820B1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
10/09/1996CN1133047A Therapeutic peptide derivatives
10/08/1996US5563121 Phosphinate methylene ammonium linkage
10/08/1996US5563041 Method for determining platelet aggregation
10/08/1996US5563032 Mosaic polypeptide and methods for detecting the hepatitis E virus
10/03/1996WO1996030765A1 Assaying protein fragments in body fluids
10/03/1996WO1996030516A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/03/1996WO1996030512A1 Conditional expression system
10/03/1996WO1996030399A1 Cyclic peptide nuclei and derivatives thereof
10/03/1996WO1996030397A1 New peptides with immunomodulatory effects
10/03/1996WO1996030332A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/03/1996WO1996030057A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
10/03/1996WO1996030055A2 Radiolabeled peptides for diagnosis and therapy
10/03/1996WO1996030035A1 β-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS
10/03/1996CA2217009A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996CA2215720A1 .beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
10/03/1996CA2214451A1 Conditional expression system
10/03/1996CA2189656A1 New peptides with immunomodulatory effects
10/02/1996EP0734394A1 Peptide inhibitors of cxc intercrine molecules
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996CN1132210A Cyclohexapeptides and their mixtures, process for preparing them, and their use
10/01/1996US5561220 Technetium-99m labeled peptides for imaging inflammation
10/01/1996US5561107 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
09/1996
09/26/1996WO1996029347A1 Thrombin inhibitors based on the amino acid sequence of hirudin
1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 423